You have 9 free searches left this month | for more free features.

City

Miami (1)

Orlando (1)

Saint Paul (1)

Triest (1)

Condition

Bacterial Infections (2)

Pharmacokinetics (1)

Pyelonephritis (1)

Overall Status

Not yet recruiting (3)

Terminated (1)

Sign in for free

Phase

phase 1 (3)

phase 3 (1)

Sponsor

Qpex Biopharma, Inc. (2)

IRCCS Burlo Garofolo (1)

Venatorx Pharmaceuticals, Inc. (1)

Collaborator

Biomedical Advanced Research and Development Authority (2)

Shionogi Inc. (2)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Intervention

ceftibuten (4)

xeruborbactam oral prodrug (2)

ceftibuten placebo (1)

vnrx-7145 (1)

xeruborbactam oral prodrug placebo (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (3)

Other (1)

Study Type

Interventional (4)

ceftibuten

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Bacterial Infections Trial (Xeruborbactam Oral Prodrug, Ceftibuten, Xeruborbactam Oral Prodrug Placebo)

Not yet recruiting

Bacterial Infections

Xeruborbactam Oral Prodrug
+3 more

(no location specified)

Oct 6, 2023

Bacterial Infections Trial (Xeruborbactam Oral Prodrug, Ceftibuten)

Not yet recruiting

Bacterial Infections

Xeruborbactam Oral Prodrug
Ceftibuten

(no location specified)

Nov 27, 2023

Pharmacokinetics Trial in Miami, Orlando, Saint Paul (VNRX-7145, Ceftibuten)

Not yet recruiting

Pharmacokinetics

VNRX-7145
Ceftibuten

Miami, Florida
+2 more

Aug 3, 2022

Pyelonephritis Trial in Triest (ceftibuten)

Terminated

Pyelonephritis

ceftibuten

Triest, Italy

Institute for Child Health Burlo Garofolo

Feb 15, 2012